Sera Prognostics Investor Relations Material
Latest events
Q2 2025
Sera Prognostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sera Prognostics Inc
Access all reports
Sera Prognostics Inc. is a biotechnology company focused on developing diagnostic tests that predict pregnancy-related complications. The company uses proteomic technologies to identify biomarkers that assess the risk of conditions such as preterm birth and other adverse pregnancy outcomes. Sera Prognostics aims to provide healthcare providers with actionable information to improve maternal and neonatal health through early detection and intervention. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Key slides for Sera Prognostics Inc
Corporate Presentation
Sera Prognostics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Sera Prognostics Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
SERA
Country
🇺🇸 United States